B cell targeted therapies in autoimmune disease

Area of Science:

• Immunology
• Autoimmunity
• Therapeutics

Background:

• B cell-targeted therapies are approved for numerous autoimmune diseases, including organ-specific and systemic conditions.
• Pathogenic roles of B cells, both autoantibody-dependent and independent, vary across diseases and patient subsets.
• Recent findings highlight the diversity of human B cell subsets involved in disease pathogenesis and novel activation pathways.

Purpose of the Study:

• To review the variability in patient responses to B cell-targeted therapies.
• To focus on the diversity of human B cells and plasma cells in autoimmunity.
• To discuss promising new B cell-targeted therapies.

Main Methods:

• Literature review of recent advances in B cell subsets and function.
• Analysis of pathogenic roles of B cells in autoimmune diseases.
• Discussion of novel pathways of B cell activation and therapeutic approaches.

Main Results:

• Significant advances in understanding human B cell subsets and their functions in autoimmunity.
• A nuanced view of how diverse B cells contribute to autoimmune diseases.
• An expanding range of B cell-targeted therapies available.

Conclusions:

• Understanding B cell diversity is crucial for optimizing B cell-targeted therapies.
• New approaches are emerging to target autoreactive B cells and plasma cells effectively.
• Personalized therapeutic strategies may improve outcomes in autoimmune diseases.